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Introduction
The following abstracts are part of an ongoing series
of articles produced by the Cochrane Collaborative
Review Group on Peripheral Vascular Diseases,
which is part of the Cochrane Collaboration. The
reviews are published in full on `` The Cochrane
Library'', a quarterly electronic journal available on
CD-ROM and via the Internet. The electronic format
allows Cochrane reviews to accommodate new data as
they become available, making the library a consist-
ently up-to-date source of information over time.
The abstracts appearing on the Cochrane Library
are now presented in a different, simpler, less scientif-
ic format than the abstracts usually presented here to
permit greater accessibility to the public. However, the
substance of both versions is the same. Cochrane
reviews are now indexed on MedLine.
If you are interested in writing a Cochrane review or
contributing to the activities of the Cochrane Periph-
eral Vascular Diseases Group please contact:
Professor FGR Fowkes,
Cochrane Collaborative Review Group on
Peripheral Vascular Diseases
Public Health Sciences
University of Edinburgh
Teviot Place
Edinburgh EH8 9AG
Tel. 44 (0) 131 650 3220
Fax. 44 (0) 131 650 6904
Any comments or criticisms on Cochrane reviews/
abstracts should be made through the comments/cri-
ticisms facility on the Cochrane Library, or by contact-
ing the group at the above address.
Abstracts
Abstract. Surgery for varicose veins: use of
tourniquet.
K. A. Rigby, S. J. Palfreyman, C. Beverley and
J. A. Michaels
Date of most recent substantive amendment: 17 December
2001
Background
Varicose vein surgery is a common surgical procedure
but there is no consensus regarding the best surgical
technique. The use of tourniquets during varicose
vein surgery has been advocated as a means of
reducing the potential for blood loss during the
operation.
Objectives
To identify whether the use of a tourniquet should be
recommended when undertaking surgery for the
management of primary varicose veins.
Search strategy
The reviewers searched the Cochrane Peripheral
Vascular Diseases Group trials register (last searched
November 2001), thirteen electronic bibliographic
databases, including the Cochrane Controlled Trials
Register (CCTR) (last searched Issue 3, 2001), covering
biomedical science, social science, health economic
and grey literature (including current research). In
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addition, the reference lists of relevant articles were
checked and various health services research related
resources were consulted via the Internet. These
included health economics and HTA organisations,
guideline producing agencies, generic research and
trials registers, and specialist sites.
Selection criteria
All studies described as randomised controlled trials
that examined the use of tourniquets during surgery
for patients with primary varicose veins were included.
Data collection and analysis
Data from eligible studies were extracted and sum-
marised independently by two reviewers. All studies
were cross-checked independently by the reviewers.
Main results
A total of twenty published papers and nineteen stu-
dies were identified. Only three of these were rando-
mised controlled trials and were included in the
review. Sixteen studies were excluded as they were
non-randomised and one was a duplicate study. All
three trials had a small sample size and reported the
trial design, outcome measures and analysis poorly.
There were also variations in the outcome measures
used between the trials. In addition, there was no
consistency on the reporting of mean and medians
for blood loss during the operation. It was therefore
not possible to pool the data to perform meta-analysis.
However, the reported blood loss when using a tour-
niquet was between 0 and 16 mls compared to between
107 and 133 mls when not using a tourniquet (p5 0.01).
Reviewers' conclusions
Although there were significant quality issues with
the available evidence, the use of a tourniquet would
appear to reduce blood loss during surgery. There
were no reported differences between the use or
non-use of a tourniquet in terms of complications
and morbidity. However, the available trials were not
of sufficient size to detect rarer complications such as
nerve damage.
Abstract. Chelation therapy for atherosclerotic
cardiovascular disease
M. V. Villarruz, A. Dans and F. Tan
Date of most recent substantive amendment: 7 August 2002
Background
Chelation therapy is being promoted and practiced all
over the world as a form of alternative medicine in the
treatment of atherosclerotic cardiovascular disease. It
has been recommended as a safe, relatively inexpen-
sive and non-surgical method of restoring blood flow
in atherosclerotic vessels. At present, the benefit of
chelation therapy remains controversial at best.
Objectives
The objective of this review is to assess the effects of
ethylene diamine tetraacetic acid (EDTA) chelation
therapy on clinical outcomes among patients with
atherosclerotic cardiovascular disease.
Search strategy
The reviewers searched the Cochrane Peripheral Vas-
cular Diseases Group Trials Register, (last searched
July 2002), the Cochrane Controlled Trials Register,
(Cochrane Library Issue 2, 2002), MEDLINE and
EMBASE for published articles and other relevant
articles. Studies were also requested through corres-
pondence with known Filipino practitioners of the
procedure.
Selection criteria
Studies were included if they were randomized con-
trolled trials of EDTA chelation therapy versus pla-
cebo or no treatment in patients with atherosclerotic
cardiovascular disease. Main outcome measures con-
sidered included either total or cause-specific mortal-
ity, non-fatal cardiovascular events, direct or indirect
measurement of disease severity, subjective measures
of improvement or adverse events.
Data collection and analysis
Two reviewers (MVV, FT) extracted data and assessed
trial quality independently. Unresolved issues were
considered by a third reviewer (ALD). Discrepancies
were discussed until a consensus was reached.
Authors were contacted for additional information.
Main results
A total of five studies was included in the review.
Mortality, non-fatal events, and cerebrovascular
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events were not reported in any of the studies. Four of
the studies, with a total recruitment rate of
250 participants, showed no significant difference
in the following outcomes: direct or indirect
measurement of disease severity and subjective
measures of improvement. One of the studies,
which included only 10 patients, was interrupted
prematurely, because of an apparent treatment
effect. However, relevant data were not available
in the report and have been requested from the
authors.
Reviewers' conclusions
At present, there is insufficient evidence to decide on
the effectiveness or ineffectiveness of chelation ther-
apy in improving clinical outcomes of patients with
atherosclerotic cardiovascular disease. This decision
must be preceded by conducting randomized con-
trolled trials that would include endpoints that show
the effects of chelation therapy on longevity and qual-
ity of life among patients with atherosclerotic cardio-
vascular disease.
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